Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Oruvail 2.5% Gel.
| Pharmaceutical Form |
|---|
|
Gel. |
Ketoprofen 2.5% w/w.
| Active Ingredient | Description | |
|---|---|---|
| Ketoprofen |
Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions. |
| List of Excipients |
|---|
|
Carbopol |
Cardboard carton containing aluminium tube internally coated with polycondensed epoxyphenol varnish with the tip sealed with the same material containing either 5, 7.5, 10, 15, 25, 30, 50, 60, 100 or 150g of gel.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0627
Date of First Authorisation: 29 July 2010
| Drug | Countries | |
|---|---|---|
| ORUVAIL | Australia, Ireland, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
